Discover open access scientific publications

Search, annotate, share and cite publications

Publications by G Finazzi

Incidence and Risk Factors for Bleeding in 1104 Patients With Essential Thrombocythemia or Prefibrotic Myelofibrosis Diagnosed According to the 2008 WHO Criteria

Leukemia

English

Related publications

Validation of the IPSET Score for Thrombosis in Patients With Prefibrotic Myelofibrosis

English

Recent Advances in Understanding Myelofibrosis and Essential Thrombocythemia

English

Dynamic Model for Predicting Death Within 12 Months in Patients With Primary or Post–Polycythemia Vera/Essential Thrombocythemia Myelofibrosis

Journal of Clinical Oncology

English

JAK2 Mutation Status, Hemostatic Risk Factors and Thrombophilic Factors in Essential Thrombocythemia (ET) Patients

Folia Histochemica et Cytobiologica

English

Myelofibrosis With Bleeding Jejunoileal Angiodysplasia Diagnosed by Intraoperative Endoscopy.

Postgraduate Medical Journal

Medicine

1991

English

Reply to ‘Re: Essential Thrombocythemia in Young Individuals: Frequency and Risk Factors for Vascular Events and Evolution to Myelofibrosis in 126 Patients. Alvarez-Larrán Et Al. Leukemia 2007; 21: 1218–1223’

English

Reply to ‘Re: Essential Thrombocythemia in Young Individuals: Frequency and Risk Factors for Vascular Events and Evolution to Myelofibrosis in 126 Patients. Alvarez-Larrán a Et Al.’ by Westerman Et Al.

English

ASXL1 Mutations in Chinese Patients With Essential Thrombocythemia

Experimental and Therapeutic Medicine

English

Hydroxyurea Compared With Anagrelide in High-Risk Essential Thrombocythemia

New England Journal of Medicine

Medicine

2005

English

Amanote Research

Discover open access scientific publications

Search, annotate, share and cite publications

Publications by G Finazzi

Incidence and Risk Factors for Bleeding in 1104 Patients With Essential Thrombocythemia or Prefibrotic Myelofibrosis Diagnosed According to the 2008 WHO Criteria

Related publications

Validation of the IPSET Score for Thrombosis in Patients With Prefibrotic Myelofibrosis

Recent Advances in Understanding Myelofibrosis and Essential Thrombocythemia

Dynamic Model for Predicting Death Within 12 Months in Patients With Primary or Post–Polycythemia Vera/Essential Thrombocythemia Myelofibrosis

JAK2 Mutation Status, Hemostatic Risk Factors and Thrombophilic Factors in Essential Thrombocythemia (ET) Patients

Myelofibrosis With Bleeding Jejunoileal Angiodysplasia Diagnosed by Intraoperative Endoscopy.

Reply to ‘Re: Essential Thrombocythemia in Young Individuals: Frequency and Risk Factors for Vascular Events and Evolution to Myelofibrosis in 126 Patients. Alvarez-Larrán Et Al. Leukemia 2007; 21: 1218–1223’

Reply to ‘Re: Essential Thrombocythemia in Young Individuals: Frequency and Risk Factors for Vascular Events and Evolution to Myelofibrosis in 126 Patients. Alvarez-Larrán a Et Al.’ by Westerman Et Al.

ASXL1 Mutations in Chinese Patients With Essential Thrombocythemia

Hydroxyurea Compared With Anagrelide in High-Risk Essential Thrombocythemia